These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 10834181)

  • 61. [Recurrent infarct during aspirin therapy].
    Stiegler H
    Internist (Berl); 1997 Apr; 38(4):361. PubMed ID: 9213576
    [No Abstract]   [Full Text] [Related]  

  • 62. [Effect of acenocoumarol and aspirin on platelet function, markers of thrombinemia, and intracardiac thrombosis in patients with atrial fibrillation].
    Zharkova TV; Ataullakhanova DM; Bykova ES; Kropacheva ES; Dobrovol'skiĭ AB; Titaeva EV; Panchenko EP
    Kardiologiia; 2007; 47(6):31-6. PubMed ID: 18260872
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Cerebral infarctions. Study of their prevention].
    Gautier JC; Morelot D
    Nouv Presse Med; 1975 Oct; 4(36):2575-80. PubMed ID: 1202432
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [The use of antithrombotic drugs in patients with chronic atrial fibrillation in a local health area].
    Aloy-Duch A; Cuenca-Luque R; Rollán-Serrano E; Casanova-Sandoval JM
    Med Clin (Barc); 1999 Apr; 112(12):454-6. PubMed ID: 10320959
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [The assessment of the thromboembolic risk and the role of antithrombotic prophylaxis in nonrheumatic atrial fibrillation].
    Fera MS; Giovannini E
    G Ital Cardiol; 1999 Feb; 29(2):193-213. PubMed ID: 10088078
    [No Abstract]   [Full Text] [Related]  

  • 66. Treatment of arterial thromboembolic disease.
    Meyer BJ; Chesebro JH
    Curr Opin Hematol; 1994 Sep; 1(5):336-40. PubMed ID: 9371302
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [The implications of thromboembolism in chronic heart failure].
    Ambăruş V; Rezuş C; Ghiuru R; Ionescu S; Manea P; Leuciuc E; Artenie R; Sandru V; Cosovanu A
    Rev Med Chir Soc Med Nat Iasi; 2002; 106(1):107-11. PubMed ID: 12635370
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Risks in atrial fibrillation and simultaneous renal failure].
    Habich S
    Dtsch Med Wochenschr; 2012 Sep; 137(38):1840. PubMed ID: 23133847
    [No Abstract]   [Full Text] [Related]  

  • 69. Alternate-day dosing of aspirin in atrial fibrillation. LASAF Pilot Study Group.
    Posada IS; Barriales V
    Am Heart J; 1999 Jul; 138(1 Pt 1):137-43. PubMed ID: 10385777
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cost-Effectiveness of antiarrhythmic drugs for prevention of thromboembolism in patients with paroxysmal atrial fibrillation.
    Jpn Circ J; 2001 Sep; 65(9):765-8. PubMed ID: 11548872
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Alternate-day dosing of aspirin in atrial fibrillation: A critical evaluation.
    Howes CJ; Ezekowitz MD
    Am Heart J; 1999 Jul; 138(1 Pt 1):13. PubMed ID: 10385755
    [No Abstract]   [Full Text] [Related]  

  • 72. Letter by Barrios et al regarding article, "Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women".
    Barrios V; Escobar C; Echarri R
    Circulation; 2010 Feb; 121(5):e29. PubMed ID: 20142460
    [No Abstract]   [Full Text] [Related]  

  • 73. [Resistance to aspirin: prevalence, mechanisms of action and association with thromboembolic events. A narrative review].
    Cañivano Petreñas L; García Yubero C
    Farm Hosp; 2010; 34(1):32-43. PubMed ID: 20144820
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Acetylsalicylic acid for stroke prevention in atrial fibrillation: a conspiracy that needs to end?
    Lau YC; Lip GY
    Europace; 2014 May; 16(5):619-20. PubMed ID: 24284988
    [No Abstract]   [Full Text] [Related]  

  • 75. [When not to prescribe chronic treatment to the patient with atrial fibrillation].
    Scardi S; Mazzone C
    G Ital Cardiol; 1999 Nov; 29(11):1378-80. PubMed ID: 10609146
    [No Abstract]   [Full Text] [Related]  

  • 76. Triflusal: a review of its use in cerebral infarction and myocardial infarction, and as thromboprophylaxis in atrial fibrillation.
    Murdoch D; Plosker GL
    Drugs; 2006; 66(5):671-92. PubMed ID: 16620146
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Case report of paroxysmal atrial fibrillation and anticoagulation.
    Reis S; Hermoni D; Livingstone P; Borkan J
    BMJ; 2002 Nov; 325(7371):1018-20. PubMed ID: 12411364
    [No Abstract]   [Full Text] [Related]  

  • 78. Risk factors for thromboembolism during aspirin therapy in patients with atrial fibrillation: The stroke prevention in atrial fibrillation study.
    Stroke Prevention in Atrial Fibrillation Investigators
    J Stroke Cerebrovasc Dis; 1995; 5(3):147-57. PubMed ID: 26486811
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Frequency of thromboembolic mishaps in cardiopathies with auricular fibrillation with or without anticoagulant treatment].
    Cárdenas M; Stevens H; Stevens I; Zajarías S
    Arch Inst Cardiol Mex; 1968; 38(6):792-9. PubMed ID: 5711371
    [No Abstract]   [Full Text] [Related]  

  • 80. Aspirin attenuates the incidence of silent brain lesions in patients with nonvalvular atrial fibrillation.
    Sato H; Koretsune Y; Fukunami M; Kodama K; Yamada Y; Fujii K; Kitagawa K; Hori M
    Circ J; 2004 May; 68(5):410-6. PubMed ID: 15118280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.